Caris Life Sciences, Inc. Common Stock (CAI) Stock Analysis

Caris Life Sciences, Inc. Common Stock (CAI) is a publicly traded company in the HEALTHCARE sector. It trades at $16.52, carries a market capitalization of $4.65B. This page summarizes the public market data, fundamentals, and frequently asked questions for CAI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $16.52
• Market Cap: $4.65B
• EPS: $-2.76
• 52-Week High: $42.50
• 52-Week Low: $14.19

Market Sentiment

Caris Life Sciences, Inc. Common Stock currently has a Neutral sentiment score of 0.02.

About Caris Life Sciences, Inc. Common Stock

CAI International, Inc. is a prominent global transportation finance company focused on the acquisition and management of intermodal shipping containers and related equipment. Headquartered in San Francisco, California, CAI leverages its considerable industry expertise to deliver innovative and efficient financing solutions to a diverse array of customers across the United States, Europe, and Asia. Committed to operational excellence and exceptional customer service, CAI is strategically posi...

GNG Research Analysis

GNG Research scores Caris Life Sciences, Inc. Common Stock (CAI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CAI.

Frequently Asked Questions

Does CAI pay dividends?

Caris Life Sciences, Inc. Common Stock (CAI) does not currently pay a regular dividend.

What is CAI's market cap?

Caris Life Sciences, Inc. Common Stock (CAI) has a market capitalization of $4.65B with a current stock price of $16.52.